Astellas Pharma Inc. (ALPMF)
OTCMKTS
· Delayed Price · Currency is USD
10.10
0.00 (0.00%)
Jun 3, 2025, 8:00 PM EDT
Astellas Pharma Employees
Astellas Pharma had 14,754 employees as of March 31, 2024. The number of employees increased by 270 or 1.86% compared to the previous year.
Employees
14,754
Change (1Y)
270
Growth (1Y)
1.86%
Revenue / Employee
$865,547
Profits / Employee
$22,969
Market Cap
17.25B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Endo Inc. | 3,116 |
| Tian'an Technology Group | 8 |
| Elite Pharmaceuticals | 64 |
| CytoDyn | 9 |
| Glass House Brands | 374 |
| Northwest Biotherapeutics | 25 |
| American Oncology Network | 1,914 |
| Silence Therapeutics | 116 |
Astellas Pharma News
- 8 days ago - Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2 - PRNewsWire
- 10 days ago - Astellas Announces Second Annual Patient Advocacy Organization (PAO) Action Week™ To Empower Patients and Caregivers - PRNewsWire
- 15 days ago - Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer - Benzinga
- 17 days ago - Astellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio - PRNewsWire
- 5 weeks ago - Astellas to Present New Data in Geographic Atrophy at Upcoming Ophthalmology Annual Congresses - PRNewsWire
- 5 weeks ago - Astellas Pharma Inc. (ALPMF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Astellas Pharma reports FY results - Seeking Alpha
- 7 weeks ago - Zydus Lifesciences confirms losing US patent case to Astellas in mirabegron litigation - Business Upturn